Kurt A. Gustafson

Filings by Kurt A. Gustafson span 4 companies, the busiest being OmniAb, Inc., Xencor Inc and Spectrum Pharmaceuticals Inc. In total, 28 filings cover trades dated from 23 February 2022 to 16 June 2026.

Market trades split into 1 purchase (€27k) and 4 sales (€81k). The net balance comes to €54k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 11 share grants and 12 option exercises. Since January 2026: no purchases and 1 sale on the market.

On 8 July 2026 came the latest disclosure, a share grant in Xencor Inc. The most recent open-market purchase was published on 29 November 2022, 1,419 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.